Precursor Ventures

Precursor Ventures is an early-stage venture capital firm based in San Francisco, California, renowned for its commitment to investing in promising software and hardware companies from their earliest stages. Established in 2015 by Charles Hudson, the firm primarily focuses on pre-seed and seed investments, often serving as the crucial first institutional investor for burgeoning startups. Their investment philosophy is distinct, placing a strong emphasis on investing in people over product at the earliest stage of the entrepreneurial journey, believing that exceptional founders are the bedrock of successful ventures.

Precursor Ventures is dedicated to fostering a diverse and inclusive entrepreneurial ecosystem. They actively seek out and support a broad spectrum of founders, including those from underrepresented backgrounds and first-time entrepreneurs, providing them with not only capital but also strategic guidance and mentorship. The firm's geographic focus is predominantly North America, encompassing the USA, Canada, and Mexico, where they build long-term relationships with founders to help them scale and grow their companies from inception.

Under Charles Hudson's leadership as Managing Partner, Precursor Ventures operates on a unique solo General Partner model, supported by a lean yet experienced team. This structure enables swift decision-making, often within days, a significant advantage for fast-moving early-stage companies. The firm maintains a high-volume investment strategy, making approximately 30 to 40 new investments annually. This approach allows them to engage with a wide network of founders and explore emerging areas across various sectors, including consumer applications, digital health, enterprise software, fintech, and increasingly, AI-related investments.

Precursor Ventures has built a robust portfolio of over 300 companies, demonstrating a track record of identifying high-potential ventures. Notable achievements include significant exits such as The Athletic (acquired) and Limitless (acquired by Meta), alongside backing companies that have achieved unicorn status like Juniper Square and Incredible Health. As of early 2026, the firm manages approximately $250 million USD across its funds, with its fifth fund, Fund V, closing at $66 million USD in early 2025. The firm's commitment to supporting founders through various stages, from idea to significant growth, underscores its influential role in the early-stage venture capital landscape.